| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |